1230.1000 7.90 (0.65%)
NSE May 23, 2025 15:31 PM
Volume: 734.3K
 

1230.10
0.65%
Karvy
US business declines, margins outperform: DRL's revenues increased by 7% YoY to Rs 37.9 bn (lower than our estimates of Rs 38.9 bn) primarily due to de-growth in US business on account of higher pricing pressure due to incremental competition in some of the key products.
Dr. Reddy's Laboratories Ltd. is trading above its 150 day SMA of 1228.6
More from Dr. Reddy's Laboratories Ltd.
Recommended